929 related articles for article (PubMed ID: 30484833)
1. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
[TBL] [Abstract][Full Text] [Related]
2. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
3. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries.
Reynolds KR; Khosrow-Khavar F; Dave CV
JAMA Netw Open; 2024 May; 7(5):e249465. PubMed ID: 38709533
[TBL] [Abstract][Full Text] [Related]
6. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
[TBL] [Abstract][Full Text] [Related]
7. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
8. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
[TBL] [Abstract][Full Text] [Related]
9. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Jackson LR; Kim S; Blanco R; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Kowey PR; Mahaffey KW; Hylek EM; Peterson ED; Piccini JP;
Am Heart J; 2020 Aug; 226():85-93. PubMed ID: 32526533
[TBL] [Abstract][Full Text] [Related]
10. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
11. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
[TBL] [Abstract][Full Text] [Related]
12. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study.
Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ
J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
14. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.
Derington CG; Goodrich GK; Xu S; Clark NP; Reynolds K; An J; Witt DM; Smith DH; O'Keeffe-Rosetti M; Lang DT; Ho PM; Cheetham TC; Comer AC; King JB
JAMA Netw Open; 2023 Jul; 6(7):e2321971. PubMed ID: 37410461
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
16. Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry.
Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2018 Sep; 82(10):2500-2509. PubMed ID: 30078823
[TBL] [Abstract][Full Text] [Related]
17. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
[TBL] [Abstract][Full Text] [Related]
18. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
[TBL] [Abstract][Full Text] [Related]
20. Real-world persistence with direct oral anticoagulants (DOACs) in naïve patients with non-valvular atrial fibrillation.
Ferroni E; Gennaro N; Costa G; Fedeli U; Denas G; Pengo V; Corti MC
Int J Cardiol; 2019 Aug; 288():72-75. PubMed ID: 31043323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
